Needham Reiterates Buy on OrthoPediatrics, Maintains $42 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has reiterated a Buy rating on OrthoPediatrics (NASDAQ:KIDS) and maintained a $42 price target.
August 16, 2024 | 4:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst Mike Matson has reiterated a Buy rating on OrthoPediatrics and maintained a $42 price target.
The reiteration of a Buy rating and the maintenance of a $42 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100